Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement in Japan (J-HomeCARE II)
1 other identifier
interventional
198
1 country
4
Brief Summary
The new BIOTRONIK implantable cardioverter defibrillator (ICD) family Lumax 540 is capable of measuring the intrathoracic impedance on a daily basis and transmission of impedance trend data via the Home Monitoring technology. In future, this will allow for automatic early detection of imminent decompensation at a presymptomatic stage and immediate initialization of clinical meaningful therapeutic interventions preventing heart failure (HF) related hospitalizations. The aim of this investigation is to record long-term impedance trends in heart failure patients with and without heart failure related events (hospitalizations due to acute decompensation) in order to develop algorithms for device-based early detection and warning of HF deterioration accompanied by pulmonary congestion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 heart-failure
Started Jun 2010
Typical duration for phase_4 heart-failure
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 12, 2010
CompletedFirst Posted
Study publicly available on registry
October 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedOctober 12, 2015
February 1, 2012
3.7 years
October 12, 2010
October 8, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
HF Events
Long-term impedance trends in patients with clinically relevant HF events, to support the development of impedance based detection algorithms. A posterior assessment of sensitivity and false alarm rate of the detection algorithms.
21 months follow-up
Interventions
BIOTRONIK ICD family Lumax 540 and its successors
Eligibility Criteria
You may qualify if:
- Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current guidelines or patient already implanted with a Lumax 540 device or successor
- New York Heart Association (NYHA)-class II to IV
- Left ventricular ejection fraction (LVEF) lower or equal to 35%
- Patient accepts Home Monitoring concept and has sufficient Global System for Mobile Communications (GSM) /General Packet Radio Service (GPRS) net coverage
- Increased risk for HF-related hospitalization according to pre-defined criteria
- Patient information
- Informed consent
You may not qualify if:
- Age \< 18 years
- Contraindication for ICD implantation
- Post heart transplant (HTX) or actively listed for HTX
- Acute coronary syndrome within the previous 3 months
- Chronic renal dialysis
- Pregnant or breast-feeding women
- Limited contractual capability
- Participation in another study
- Anticipated non-compliance with the follow-up scheme
- Life expectancy not longer than 1.5 years due to a non-cardiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Kokura Kinen Hospital
Kitakyushu, Fukuoka, 802-8555, Japan
Hiroshima Shimin Hospital
Hiroshima, Hiroshima, Japan
Yamada Red Cross Hospital
Ise, Mie-ken, 516-0805, Japan
Tokyo Women's Medical University
Tokyo, Tokyo, Japan
Related Publications (1)
Maier SKG, Paule S, Jung W, Koller M, Ventura R, Quesada A, Bordachar P, Garcia-Fernandez FJ, Schumacher B, Lobitz N, Takizawa K, Ando K, Adachi K, Shoda M. Evaluation of thoracic impedance trends for implant-based remote monitoring in heart failure patients - Results from the (J-)HomeCARE-II Study. J Electrocardiol. 2019 Mar-Apr;53:100-108. doi: 10.1016/j.jelectrocard.2019.01.004. Epub 2019 Jan 25.
PMID: 30739055DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shoda Morio, DR
Tokyo Women's University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2010
First Posted
October 15, 2010
Study Start
June 1, 2010
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
October 12, 2015
Record last verified: 2012-02